UE
Uy Ear Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
1.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73.9%
Neutral
26.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $31 |
45%
upside
| 5 | -18% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $35 |
94%
upside
| 4 | -39% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $35 |
43%
upside
| 2 | -14% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $35 |
58%
upside
| 4 | -11% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $175 |
33%
upside
| 1 | – |
–
| 12 Dec ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $19 |
274%
upside
| 1 | -25% |
0
%
| 2 Dec ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $10 |
36%
upside
| 1 | +46% |
0
%
| 19 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $45 |
31%
upside
| 1 | -6.2% |
0
%
| 27 Oct ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $56 |
66%
upside
| 2 | +55% |
0
%
| 24 Sep ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $85 |
196%
upside
| 2 | +41% |
0
%
| 15 May ‘25 11 months ago |
|